Azora Therapeutics, Inc. (DE) AZR
NASDAQ AZR
$4.09 +0.35 (+9.36%)
At close: Nov 13, 2026 · 4:00 PM EST

Azora Therapeutics, Inc. (DE) (AZR) Other Accumulated Expenses (2018 - 2026)

Updated

Azora Therapeutics, Inc. (DE)'s Other Accumulated Expenses came in at $2.7 million for Q3 2026, up 425.4% from $513,169 a year earlier and up 85.0% from the prior quarter.

Analysis

Azora Therapeutics, Inc. (DE) (AZR) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Azora Therapeutics, Inc. (DE)'s Other Accumulated Expenses was $660,000, up 62.9% from FY2024.

  • Other Accumulated Expenses carries a five-year compound annual growth rate of 15.4% (FY2020 to FY2025).
  • Going back by year, Other Accumulated Expenses was $405,246 in FY2024 (-3.8%), $421,365 in FY2023 (-44.7%), $761,509 in FY2022 (+46.2%) and $520,795 in FY2021 (+61.5%).
  • The Q3 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2018.
  • Year-over-year, Other Accumulated Expenses has increased for seven consecutive quarters, with growth averaging 134.8% over the last eight quarters.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2026 (growth of 425.4%), and the weakest in Q1 2024 (a decline of 82.1%).
  • Business Quant data shows AZR's Other Accumulated Expenses at $1.46 million (Q2 2026), $837,509 (Q1 2026) and $660,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Azora Therapeutics, Inc. (DE) 58.43 Mn -2.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.70 Mn
Jun 30, 2026 1.46 Mn
Mar 31, 2026 837,509.00
Dec 31, 2025 660,000.00
Sep 30, 2025 513,169.00
Jun 30, 2025 372,560.00
Mar 31, 2025 588,442.00
Dec 31, 2024 405,246.00
Sep 30, 2024 413,557.00
Jun 30, 2024 273,578.00
Mar 31, 2024 196,118.00
Dec 31, 2023 421,365.00
Sep 30, 2023 354,107.00
Jun 30, 2023 276,705.00
Mar 31, 2023 1.09 Mn
Dec 31, 2022 761,509.00
Sep 30, 2022 686,501.00
Jun 30, 2022 498,628.00
Mar 31, 2022 357,535.00
Dec 31, 2021 520,795.00
API Access

Azora Therapeutics, Inc. (DE) Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AZR&period=max&api_key=YOUR_API_KEY